Novadaq Technologies Upgraded by Zacks to “Outperform” (NVDQ)
Novadaq Technologies (NASDAQ:NVDQ) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a report released on Thursday, AnalystRatingsNetwork reports. The firm currently has a $19.30 target price on the stock. Zacks‘ price objective suggests a potential upside of 17.04% from the company’s current price.
Shares of Novadaq Technologies (NASDAQ:NVDQ) traded up 1.82% on Thursday, hitting $16.79. 147,349 shares of the company’s stock traded hands. Novadaq Technologies has a 52-week low of $8.53 and a 52-week high of $18.77. The stock has a 50-day moving average of $16.48 and a 200-day moving average of $15.24. The company’s market cap is $816.3 million.
Novadaq Technologies (NASDAQ:NVDQ) last released its earnings data on Tuesday, October 22nd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.11. The company had revenue of $8.90 million for the quarter, compared to the consensus estimate of $8.68 million. The company’s revenue for the quarter was up 56.8% on a year-over-year basis.
Several other analysts have also recently commented on the stock. Analysts at William Blair initiated coverage on shares of Novadaq Technologies in a research note to investors on Friday, November 15th. They set an “outperform” rating and a $2.00 price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of Novadaq Technologies from C$18.00 to C$22.00 in a research note to investors on Wednesday, October 23rd. They now have a “buy” rating on the stock. Finally, analysts at JMP Securities raised their price target on shares of Novadaq Technologies from C$15.00 to C$20.00 in a research note to investors on Wednesday, October 23rd. They now have an “outperform” rating on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the company’s stock. Novadaq Technologies presently has a consensus rating of “Buy” and a consensus price target of $14.76.
Novadaq Technologies Inc develops and commercializes medical imaging and therapeutic devices for use in the operating room.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.